The Department of Justice on Thursday accused Guidant, a Boston Scientific unit, of not informing the FDA of failures in three models of implantable defibrillators, which have been linked to at least seven deaths. A spokesman for Boston Scientific said, "We continue to believe that Guidant and its employees acted in good faith and with the intention of complying with applicable laws and regulations."

Related Summaries